Ann Arbor, Michigan, USA | June 23, 2022 130,000-square-foot plant in Ann Arbor, Michigan Number of jobs is expected to more than double within three years Opening of facility by year end 2023 Ground-breaking Ceremony for Center of Excellence in Ann Arbor, Michigan, June 23, 2022 Sartorius, a leading international partner of the life science... Read more
Göttingen, January 6, 2021 Proposed transaction builds on both companies’ strategic R&D partnership Strengthens Sartorius position in downstream bioprocessing The life science company Sartorius today announced it has entered into an agreement through its subgroup Sartorius Stedim Biotech to acquire the chromatography process equipment division of Novasep. The parties agreed not to disclose the purchase... Read more
Göttingen, December 9, 2020 Transaction provides a complementary fit with Sartorius’ separation portfolio, adding innovative crossflow filtration units for easy-to-use bioprocessing devices Technology is especially suited to gene and cell therapy applications, vaccine production and intensified bioprocessing The life science company Sartorius today acquired U.S.‑based purification expert WaterSep BioSeparations LLC through its subgroup Sartorius Stedim Biotech.... Read more
3/23/2020 The universal digital platform from Metrohm integrates the latest laboratory balance from Sartorius Thanks to an extension (QApp) implemented on the balance, Cubis® II from Sartorius has become a fully integrated module of the OMNIS platform. Opening OMNIS to leading third-party manufacturers underlines the commitment of the global market leader in titration to create the... Read more
Danaher Reaches Agreement To Sell Certain Businesses To Sartorius AG As Part Of The GE Biopharma Acquisition Regulatory Process WASHINGTON, Oct. 21, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) today announced that it has signed an agreement to sell its label-free biomolecular characterization, chromatography hardware and resins, and microcarriers and particle validation standards businesses to... Read more
Göttingen, Germany | Yauco, Puerto Rico – June 18, 2019 Investment of more than 100 million U.S. dollars Area designed for future growth After investing more than 100 million U.S. dollars, Sartorius, a leading international partner of biopharmaceutical research and the industry, started up its expanded manufacturing operations in Yauco, Puerto Rico. The U.S. market is... Read more
Göttingen, March 28, 2019 At today’s meeting, the Supervisory Board of Sartorius AG passed the resolution to extend the appointment of Rainer Lehmann as a member of the Executive Board by a five-year period to February 28, 2025. Lehmann has been with Sartorius since 1999 with an interruption of about two years and has been... Read more
Goettingen | Germany, March 05, 2019 Sartorius Stedim Biotech (SSB), a leading supplier for the biopharmaceutical industry, and Novasep based in Pompey, France, have entered into a collaboration agreement in the area of chromatography and single-use bioprocessing. Novasep provides various products and services to the life science industry, based on specialized technologies. In particular, this... Read more
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories. Andrew Alliance S.A. and Sartorius today announced the launch of the Andrew Alliance Pipette+ system, which uniquely provides both full traceability and improved repeatability in manual pipetting for life science laboratories. Andrew Alliance, the robotics company... Read more
Göttingen, Germany – January 31, 2019: Sartorius, a leading international partner of biopharmaceutical research and the industry, is pleased to announce that it has joined NIIMBL, the National Institute for Innovation in Manufacturing Biopharmaceuticals headquartered in Newark, Delaware, USA. The Institute, launched in 2017, is a public-private partnership and has an extensive network of academic and... Read more